Business · 12/07/2022Updated: 10/17/2026 · 1 min read
FDA Revokes Emergency Use Authorization for Fresenius Propoven 2% Emulsion
Summary
The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for Fresenius Propoven 2% Emulsion, a medication used to treat pain, effective May 10, 2022, under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →